TY - JOUR
T1 - Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections
T2 - a European multicenter cohort study
AU - on behalf of the coVAPid study Group
AU - Rouzé, Anahita
AU - Martin-Loeches, Ignacio
AU - Povoa, Pedro
AU - Makris, Demosthenes
AU - Artigas, Antonio
AU - Bouchereau, Mathilde
AU - Lambiotte, Fabien
AU - Metzelard, Matthieu
AU - Cuchet, Pierre
AU - Boulle Geronimi, Claire
AU - Labruyere, Marie
AU - Tamion, Fabienne
AU - Nyunga, Martine
AU - Luyt, Charles Edouard
AU - Labreuche, Julien
AU - Pouly, Olivier
AU - Bardin, Justine
AU - Saade, Anastasia
AU - Asfar, Pierre
AU - Baudel, Jean Luc
AU - Beurton, Alexandra
AU - Garot, Denis
AU - Ioannidou, Iliana
AU - Kreitmann, Louis
AU - Llitjos, Jean François
AU - Magira, Eleni
AU - Mégarbane, Bruno
AU - Meguerditchian, David
AU - Moglia, Edgar
AU - Mekontso-Dessap, Armand
AU - Reignier, Jean
AU - Turpin, Matthieu
AU - Pierre, Alexandre
AU - Plantefeve, Gaetan
AU - Vinsonneau, Christophe
AU - Floch, Pierre Edouard
AU - Weiss, Nicolas
AU - Ceccato, Adrian
AU - Torres, Antoni
AU - Duhamel, Alain
AU - Nseir, Saad
AU - Favory, Raphaël
AU - Preau, Sébastien
AU - Jourdain, Mercé
AU - Poissy, Julien
AU - Bouras, Chaouki
AU - Saint Leger, Piehr
AU - Fodil, Hanane
AU - Aptel, François
AU - Cilloniz, Catia
N1 - Funding Information:
Raphaël Favory: CHU de Lille, Centre de Réanimation, F-59000 Lille, France, Sébastien Preau: CHU de Lille, Centre de Réanimation, F-59000 Lille, France, Mercé Jourdain: CHU de Lille, Centre de Réanimation, F-59000 Lille, France, Julien Poissy: CHU de Lille, Centre de Réanimation, F-59000 Lille, France, Chaouki Bouras: Service de Réanimation polyvalente, Centre Hospitalier de Valenciennes, Valenciennes, France, Piehr Saint Leger: Service de Réanimation polyvalente, Centre Hospitalier de Valenciennes, Valenciennes, France, Hanane Fodil: Service de Réanimation polyvalente, Centre Hospitalier de Valenciennes, Valenciennes, France, François Aptel: Department of Intensive Care, François Mitterrand University Hospital, Dijon, France, Thierry Van Der Linden: Médecine intensive réanimation, Hôpital Saint Philibert GHICL, Université catholique, Lille, France, Arnaud W. Thille: CHU de Poitiers, Médecine Intensive Réanimation, CIC 1402 ALIVE, Université de Poitiers, Poitiers, France, Elie Azoulay: Service de médecine intensive et réanimation, hôpital Saint-Louis, 1 Avenue Claude Vellefaux, 75010, Paris, France, Frédéric Pene: Medical Intensive Care Unit, Cochin Hospital, AP-HP. Centre, & Université de Paris, Paris, France.
Funding Information:
This study was supported in part by a grant from the French government through the « Programme Investissement d’Avenir» (I-SITE ULNE) managed by the Agence Nationale de la Recherche (coVAPid project). The funders of the study had no role in the study design, data collection, analysis, or interpretation, writing of the report, or decision to submit for publication.
Funding Information:
AR received personal fees from MaatPharma, IML received personal fees from MSD, and Gilead. AA received personal fees from Lilly Foundation, and grants from Grifols and Fischer & Paykel. CEL received personal fees from Bayer, Merck, Aerogen, Biomérieux, ThermoFischer Brahms, and Carmat. NW received personal fees from MedDay pharmaceuticals. SN received personal fees from MSD, Bio Rad, BioMérieux, Gilead, and Pfizer. All other authors declare no competing interests.
Publisher Copyright:
© 2021, Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2021/2
Y1 - 2021/2
N2 - Purpose: Although patients with SARS-CoV-2 infection have several risk factors for ventilator-associated lower respiratory tract infections (VA-LRTI), the reported incidence of hospital-acquired infections is low. We aimed to determine the relationship between SARS-CoV-2 pneumonia, as compared to influenza pneumonia or no viral infection, and the incidence of VA-LRTI. Methods: Multicenter retrospective European cohort performed in 36 ICUs. All adult patients receiving invasive mechanical ventilation > 48 h were eligible if they had: SARS-CoV-2 pneumonia, influenza pneumonia, or no viral infection at ICU admission. VA-LRTI, including ventilator-associated tracheobronchitis (VAT) and ventilator-associated pneumonia (VAP), were diagnosed using clinical, radiological and quantitative microbiological criteria. All VA-LRTI were prospectively identified, and chest-X rays were analyzed by at least two physicians. Cumulative incidence of first episodes of VA-LRTI was estimated using the Kalbfleisch and Prentice method, and compared using Fine-and Gray models. Results: 1576 patients were included (568 in SARS-CoV-2, 482 in influenza, and 526 in no viral infection groups). VA-LRTI incidence was significantly higher in SARS-CoV-2 patients (287, 50.5%), as compared to influenza patients (146, 30.3%, adjusted sub hazard ratio (sHR) 1.60 (95% confidence interval (CI) 1.26 to 2.04)) or patients with no viral infection (133, 25.3%, adjusted sHR 1.7 (95% CI 1.2 to 2.39)). Gram-negative bacilli were responsible for a large proportion (82% to 89.7%) of VA-LRTI, mainly Pseudomonas aeruginosa, Enterobacter spp., and Klebsiella spp. Conclusions: The incidence of VA-LRTI is significantly higher in patients with SARS-CoV-2 infection, as compared to patients with influenza pneumonia, or no viral infection after statistical adjustment, but residual confounding may still play a role in the effect estimates.
AB - Purpose: Although patients with SARS-CoV-2 infection have several risk factors for ventilator-associated lower respiratory tract infections (VA-LRTI), the reported incidence of hospital-acquired infections is low. We aimed to determine the relationship between SARS-CoV-2 pneumonia, as compared to influenza pneumonia or no viral infection, and the incidence of VA-LRTI. Methods: Multicenter retrospective European cohort performed in 36 ICUs. All adult patients receiving invasive mechanical ventilation > 48 h were eligible if they had: SARS-CoV-2 pneumonia, influenza pneumonia, or no viral infection at ICU admission. VA-LRTI, including ventilator-associated tracheobronchitis (VAT) and ventilator-associated pneumonia (VAP), were diagnosed using clinical, radiological and quantitative microbiological criteria. All VA-LRTI were prospectively identified, and chest-X rays were analyzed by at least two physicians. Cumulative incidence of first episodes of VA-LRTI was estimated using the Kalbfleisch and Prentice method, and compared using Fine-and Gray models. Results: 1576 patients were included (568 in SARS-CoV-2, 482 in influenza, and 526 in no viral infection groups). VA-LRTI incidence was significantly higher in SARS-CoV-2 patients (287, 50.5%), as compared to influenza patients (146, 30.3%, adjusted sub hazard ratio (sHR) 1.60 (95% confidence interval (CI) 1.26 to 2.04)) or patients with no viral infection (133, 25.3%, adjusted sHR 1.7 (95% CI 1.2 to 2.39)). Gram-negative bacilli were responsible for a large proportion (82% to 89.7%) of VA-LRTI, mainly Pseudomonas aeruginosa, Enterobacter spp., and Klebsiella spp. Conclusions: The incidence of VA-LRTI is significantly higher in patients with SARS-CoV-2 infection, as compared to patients with influenza pneumonia, or no viral infection after statistical adjustment, but residual confounding may still play a role in the effect estimates.
KW - COVID-19
KW - Critical illness
KW - SARS-CoV-2
KW - Ventilator-associated pneumonia
KW - Ventilator-associated tracheobronchitis
UR - http://www.scopus.com/inward/record.url?scp=85098496448&partnerID=8YFLogxK
U2 - 10.1007/s00134-020-06323-9
DO - 10.1007/s00134-020-06323-9
M3 - Original Article
C2 - 33388794
AN - SCOPUS:85098496448
SN - 0342-4642
VL - 47
SP - 188
EP - 198
JO - Intensive Care Medicine
JF - Intensive Care Medicine
IS - 2
ER -